Research summary ·
SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This review looked at gut acids called short-chain fatty acids (SCFAs). Gut germs make these acids from fiber in food. The team searched research databases for studies on stool levels. They compared adults with IBS to healthy people. They also looked at the IBS types called IBS-D and IBS-C. Results from the studies were pooled to get an overall picture.
What they found
Across all people with IBS, propionate levels were higher than in healthy people. Levels of acetate and butyrate did not differ. In IBS-D, propionate was higher in a steady way. In IBS-C, total SCFA levels were lower, and studies agreed on this. In IBS-C, the single acids showed no clear change. Most studies were judged good quality, and one was rated moderate.
What it means for patients
The authors say high propionate may serve as a sign of IBS. They see this sign mainly in IBS-D. Lower total SCFAs may be a distinct sign of IBS-C. The authors write that diet and test methods shape the mixed results.
Why it is not certain yet
No studies included people from India. So the results may not apply to people there. Results for single acids in IBS-C varied a lot between studies. The authors say new studies in India are needed to check these signs. A review can only be as good as the studies in it.
Source
SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India.
PubMed · PMID 42834635We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Irritable bowel syndrome publications